6.38
price up icon0.63%   0.04
after-market Dopo l'orario di chiusura: 6.38
loading
Precedente Chiudi:
$6.34
Aprire:
$6.27
Volume 24 ore:
170.69K
Relative Volume:
3.11
Capitalizzazione di mercato:
$194.48M
Reddito:
$4.01M
Utile/perdita netta:
$-35.01M
Rapporto P/E:
-6.7872
EPS:
-0.94
Flusso di cassa netto:
$-24.53M
1 W Prestazione:
-8.20%
1M Prestazione:
-1.69%
6M Prestazione:
+24.61%
1 anno Prestazione:
+61.93%
Intervallo 1D:
Value
$6.131
$6.6559
Intervallo di 1 settimana:
Value
$6.06
$7.00
Portata 52W:
Value
$3.81
$9.96

Xbiotech Inc Stock (XBIT) Company Profile

Name
Nome
Xbiotech Inc
Name
Telefono
512-386-2900
Name
Indirizzo
5217 WINNEBAGO LANE, AUSTIN, TX
Name
Dipendente
92
Name
Cinguettio
@xbiotech_usa
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
XBIT's Discussions on Twitter

Confronta XBIT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XBIT
Xbiotech Inc
6.38 194.48M 4.01M -35.01M -24.53M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-06-14 Iniziato Piper Jaffray Overweight
2017-04-21 Downgrade Noble Financial Buy → Hold
2016-06-28 Reiterato Noble Financial Buy

Xbiotech Inc Borsa (XBIT) Ultime notizie

pulisher
Dec 20, 2024

XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

(XBIT) Proactive Strategies - Stock Traders Daily

Dec 19, 2024
pulisher
Dec 16, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Dec 16, 2024
pulisher
Dec 11, 2024

XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World

Dec 11, 2024
pulisher
Dec 08, 2024

(XBIT) Investment Analysis and Advice - Stock Traders Daily

Dec 08, 2024
pulisher
Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 30, 2024
pulisher
Nov 28, 2024

Trend Tracker for (XBIT) - Stock Traders Daily

Nov 28, 2024
pulisher
Nov 25, 2024

Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 25, 2024
pulisher
Nov 19, 2024

XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR

Nov 19, 2024
pulisher
Nov 17, 2024

How To Trade (XBIT) - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

XBiotech: Q3 Earnings Snapshot - New Haven Register

Nov 14, 2024
pulisher
Nov 13, 2024

Transforming lives for those battling cancer with the speed & precision of AIRakovina Therapeutics (TSXV: RKV) | GCFF - NAI 500

Nov 13, 2024
pulisher
Nov 08, 2024

XBiotech (NASDAQ:XBIT) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

XBiotech Inc.'s (NASDAQ:XBIT) 12% gain last week benefited both individual investors who own 49% as well as insiders - Simply Wall St

Nov 07, 2024
pulisher
Nov 06, 2024

(XBIT) Technical Data - Stock Traders Daily

Nov 06, 2024
pulisher
Oct 31, 2024

XBiotech (NASDAQ:XBIT) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat

Oct 31, 2024
pulisher
Oct 27, 2024

(XBIT) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 24, 2024

Desmoplastic Small Round Cell Tumor Treatment Market Overall - openPR

Oct 24, 2024
pulisher
Oct 23, 2024

XBiotech (NASDAQ:XBIT) Stock Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat

Oct 23, 2024
pulisher
Oct 16, 2024

How the (XBIT) price action is used to our Advantage - Stock Traders Daily

Oct 16, 2024
pulisher
Oct 14, 2024

Enerflex Ltd. (NYSE:EFXT) Stake Increased by The Manufacturers Life Insurance Company - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Alopecia Areata Market Analysis, Size, Market Report 2024-2033 - WhaTech

Oct 14, 2024
pulisher
Oct 04, 2024

76,460 Shares in XBiotech Inc. (NASDAQ:XBIT) Acquired by American Century Companies Inc. - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

American Century Companies Inc. Acquires Shares of 76,460 XBiotech Inc. (NASDAQ:XBIT) - MarketBeat

Oct 04, 2024
pulisher
Oct 01, 2024

Cancer Antigen Market Size Is Booming Worldwide with Share, Size, Top Key Players - Talented India

Oct 01, 2024
pulisher
Oct 01, 2024

Rhumbline Advisers Has $103,000 Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Oct 01, 2024
pulisher
Sep 28, 2024

Rhumbline Advisers Has $335,000 Stock Position in The First of Long Island Co. (NASDAQ:FLIC) - Defense World

Sep 28, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Buys 49,863 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Sep 25, 2024
pulisher
Sep 22, 2024

XBiotech (NASDAQ:XBIT) vs. Harmony Biosciences (NASDAQ:HRMY) Financial Contrast - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.63 - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

XBiotech (NASDAQ:XBIT) Stock Price Passes Above 50-Day Moving Average of $6.63 - MarketBeat

Sep 21, 2024
pulisher
Sep 14, 2024

Objective long/short (XBIT) Report - Stock Traders Daily

Sep 14, 2024
pulisher
Sep 13, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving Average of $6.47 - MarketBeat

Sep 13, 2024
pulisher
Sep 13, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.47 - Defense World

Sep 13, 2024
pulisher
Aug 30, 2024

Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load? - Simply Wall St

Aug 30, 2024
pulisher
Aug 29, 2024

Hidradenitis Suppurativa Market Demand, Share, Size, Trends, Forecast To 2033 - WhaTech

Aug 29, 2024
pulisher
Aug 23, 2024

Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - GlobeNewswire Inc.

Aug 23, 2024
pulisher
Aug 17, 2024

XBiotech Inc. (NASDAQ:XBIT) Stock Holdings Increased by Vanguard Group Inc. - Defense World

Aug 17, 2024
pulisher
Aug 14, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.22 - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.22 - Defense World

Aug 14, 2024
pulisher
Aug 13, 2024

XBiotech: Q2 Earnings Snapshot - CT Insider

Aug 13, 2024
pulisher
Aug 13, 2024

XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 06, 2024

(XBIT) Trading Signals - Stock Traders Daily

Aug 06, 2024
pulisher
Aug 03, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above 50 Day Moving Average of $6.35 - Defense World

Aug 03, 2024
pulisher
Aug 03, 2024

XBiotech Inc. (NASDAQ:XBIT) most popular amongst retail investors who own 51%, insiders hold 35% - Yahoo Finance

Aug 03, 2024
pulisher
Aug 03, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving Average of $6.35 - MarketBeat

Aug 03, 2024
pulisher
Jul 27, 2024

(XBIT) Investment Analysis - Stock Traders Daily

Jul 27, 2024
pulisher
Jul 26, 2024

XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest - MarketBeat

Jul 26, 2024

Xbiotech Inc Azioni (XBIT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):